Chloramphenicol stearate

This classification denotes a protein synthesis inhibitor and antibiotic C29H46Cl2N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DL2A9M9D6X, chemically known as octadecanoic acid, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl ester, but more generally known as chloramphenicol stearate, which bears US NIH Compound Identifier 83945. European Medicines Agency schedules Chloramphenicol stearate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26903. Most nations, for tariff and trade purposes, schedule chloramphenicol stearate under HS 29414000 and SITC 54139. As of Q4 2014, CHLORAMPHENICOL STEARATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCCCCCCCCCC(=O)OC[C@H]([C@@H](C1CCC(CC1)[N+](=O)[O-])O)NC(=O)C(CL)CL.